For glioma, it's all in the letters

Just a single change in one letter in the genetic code could make all the difference when it comes to the outcomes of certain types of glioma. According to a team of U.S. researchers publishing in Nature Genetics, these types of cancer make up around a fifth of all new brain cancers diagnosed annually in the U.S.

Using next-generation sequencing, the researchers found 7 SNPs (single nucleotide polymorphisms; single changes in letters of the code) that could link with types of glioma. One of these was a change from A to G, which increased the chance that the patient had a slower-growing form of the tumor, and a much better chance of survival.

"Being able to tell people that the mass in their brain is this type of tumor is actually good news, because it has a much better prognosis than other brain tumors," says Dr. Robert Jenkins at the Mayo Clinic Cancer Center.

While this is very early-stage research, it could lead to blood tests that determine what subtype of cancer patients with abnormal scans have, ultimately helping doctors decide on the best course of treatment.

- read the press release
- check out the abstract


Like what you're reading?
Click here to get more news delivered to your inbox >>

 

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.